3,4-dihydroxyphenylacetic acid has been researched along with Hyperprolactinemia in 8 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to determine the effects of acute hypoprolactinemia on tuberoinfundibular dopamine (DA) neurons using a rabbit anti-rat prolactin antiserum (PRL-AB) to immunoneutralize circulating prolactin under basal conditions and at various times after haloperidol-induced hyperprolactinemia." | 3.70 | Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies. ( Fleckenstein, AE; Hentschel, K; Lawson, DM; Lookingland, KJ; Moore, KE; Toney, TW, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Laurentiis, A | 1 |
| Pisera, D | 1 |
| Caruso, C | 1 |
| Candolfi, M | 1 |
| Mohn, C | 1 |
| Rettori, V | 1 |
| Seilicovich, A | 1 |
| Hernández, ML | 1 |
| Fernández-Ruiz, JJ | 1 |
| Navarro, M | 1 |
| de Miguel, R | 1 |
| Cebeira, M | 1 |
| Vaticón, L | 1 |
| Ramos, JA | 1 |
| Yang, JY | 1 |
| Pan, JT | 1 |
| Hentschel, K | 1 |
| Fleckenstein, AE | 1 |
| Toney, TW | 1 |
| Lawson, DM | 1 |
| Moore, KE | 1 |
| Lookingland, KJ | 1 |
| MohanKumar, PS | 1 |
| MohanKumar, SM | 1 |
| Quadri, SK | 1 |
| Voogt, JL | 1 |
| Paradisi, R | 1 |
| Grossi, G | 1 |
| Pintore, A | 1 |
| Venturoli, S | 1 |
| Porcu, E | 1 |
| Capelli, M | 1 |
| Flamigni, C | 1 |
| Mechanick, JI | 1 |
| Cohen-Becker, IR | 1 |
| Gregerson, KA | 1 |
| Selmanoff, M | 1 |
| Benfenati, F | 1 |
| Ferretti, C | 1 |
| Cimino, M | 1 |
| Vantini, G | 1 |
| Lipartiti, M | 1 |
| Muccioli, G | 1 |
| Di Carlo, R | 1 |
| Algeri, S | 1 |
8 other studies available for 3,4-dihydroxyphenylacetic acid and Hyperprolactinemia
| Article | Year |
|---|---|
Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bacterial Infections; Dopamine; Epinephrine; Hyperprolactin | 2002 |
Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Hyperprolactinemia; Inje | 1994 |
Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Cysteamine; Dopamine; Estrogens; Female; Hyp | 1994 |
Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Dopamine; Dopamine Antagon | 2000 |
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopa | 2001 |
Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Brain; Carbidopa; Chromatography, High Pressure Liquid; Disul | 1991 |
Distribution of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG) in microdissected brain structures and the pituitary gland: metabolite changes in the median eminence in response to hyperprolactinemia and suckling.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Suckling; Brain; Dissection; Glycols; Hyperprolact | 1987 |
Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Domperidone; Dopamine; Drug Administration | 1986 |